Pierre Fabre Laboratories is committed, alongside the EspeRare Foundation, to developing an innovative in utero therapy for the most common form of ectodermal dysplasia, XLHED, a rare genetic ...

Pierre Fabre Laboratories and RedRidge Bio ("RedRidge") today announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates ...

Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of Scorpion Therapeutics, Inc., of the worldwide rights for PFL-721 and ...

PFP is the US pharmaceutical subsidiary of Pierre Fabre Laboratories, a foundation-owned company with seven decades of impact. Pierre Fabre Laboratories is a global healthcare company, established in ...

The European Commission (EC) has authorized the marketing of OBGEMSA™ (vibegron) by Pierre Fabre Laboratories for the symptomatic treatment of overactive bladder syndrome in adults, a particularly ...

In 2022, Pierre Fabre Laboratories posted 2.7 billion euros in revenues, 69% of which came from international sales in 120 countries.

Contacts Press contacts : US : Pierre Fabre USA Laurent Emmanuel Saffré, 973-647-1610 [email protected] or France : Valérie Roucoules Bruneau, +33 (0)1 49 10 83 84 valerie.roucoules@pierre ...

SECAUCUS, N.J., June 18, 2025 /PRNewswire/ --Pierre Fabre Laboratories, a global healthcare company originated from France, announces the inauguration of its new US office located on 500 Plaza ...

Pierre Fabre started operation in China in 2003 and has reported strong market performance over the past 14 years. Its products are sold in more than 600 department stores in major Chinese cities.

Pierre Fabre Laboratories have received marketing authorisation in China for BRAFTOVI (encorafenib) in combination with cetuximab to treat adult patients with BRAFV600E-mutant metastatic colorectal ...

Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241 Provided by PR Newswire Jun 16, 2025, 1:00:00 AM ...